FCMV
Foresite Capital Management V’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,258,243
| Closed | -$8.62M | – | 6 |
|
|
2023
Q3 | $8.62M | Hold |
1,258,243
| – | – | 13.75% | 4 |
|
|
2023
Q2 | $13M | Hold |
1,258,243
| – | – | 9.53% | 4 |
|
|
2023
Q1 | $10.2M | Hold |
1,258,243
| – | – | 7.52% | 6 |
|
|
2022
Q4 | $19.8M | Hold |
1,258,243
| – | – | 15.39% | 3 |
|
|
2022
Q3 | $19.8M | Hold |
1,258,243
| – | – | 15.23% | 1 |
|
|
2022
Q2 | $17.6M | Hold |
1,258,243
| – | – | 12.27% | 3 |
|
|
2022
Q1 | $21.7M | Hold |
1,258,243
| – | – | 8.86% | 4 |
|
|
2021
Q4 | $18.3M | Hold |
1,258,243
| – | – | 4.49% | 5 |
|
|
2021
Q3 | $22.6M | Hold |
1,258,243
| – | – | 7.04% | 4 |
|
|
2021
Q2 | $22.1M | Hold |
1,258,243
| – | – | 8.69% | 3 |
|
|
2021
Q1 | $31.7M | Buy |
+1,258,243
| New | +$31.7M | 9.32% | 3 |
|